Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...

Iran did not rebuild its uranium enrichment capability following joint U.S.-Israeli strikes against its nuclear program last year, U.S. Director of National Intelligence (DNI) Tulsi Gabbard told a ...

NASA has updated its Artemis program, adding a new mission before the next lunar landing attempt. The first crewed moon landing in over 50 years is now targeted for 2028 as part of the Artemis 4 ...

For the first time, researchers have shown that self-assembled phosphorus chains can host genuinely one-dimensional electron behavior. Using advanced imaging and spectroscopy techniques, they ...

Vanderbilt basketball has surpassed its 2024-25 win total with a few weeks left to go in the season and has done it while demonstrating what an extra year of Mark Byington's tenure can do for it.

Blue Origin has “paused” its New Shepard program for the next two years, a move that likely signals a permanent end to the suborbital space tourism initiative. The small rocket and capsule have been ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...